| Structure |
Chemical Name |
CAS |
MF |
 |
Sulfapyrazole-13C6 |
1420043-51-1 |
|
 |
Zoalene-D5(DinitolMide-D5) |
1596379-06-4 |
C8H7N3O5 |
 |
KetaMine-D3 hydrochloride |
1073254-49-5 |
C13H17Cl2NO |
 |
Difloxacin-D3 hydrochloride hydrate(see Data Sheet) |
1173021-89-0 |
C21H20ClF2N3O3 |
|
|
SIGMA PSEUDO(TM) NARCOTIC SCENT COCAINE FORMULATION |
|
|
 |
Benzoylecgonine tetrahydrate
|
5928-96-1 |
C16H21NO5 |
 |
Butyl Paraben-13C6 |
1416711-53-9 |
C11H14O3 |
 |
AMinotriclabendazole hydrochloride |
1448346-37-9 |
C13H9Cl4N3O |
 |
Colterol-D9 acetate |
1420043-63-5 |
C14H23NO5 |
 |
HydroxyMethylclenbuterol hydrochloride |
37162-89-3 |
C12H19Cl3N2O2 |
 |
PropionylproMazine-D6 hydrochloride |
1262770-67-1 |
C20H25ClN2OS |
 |
Salbutamol acetate |
1420043-41-9 |
C15H25NO5 |
 |
(±)-N-Ethyl-α-methylphenethylaminhydrochlorid |
16105-78-5 |
C11H17N.ClH |
 |
D-AMPHETAMINE-D3 SULFATE SALT |
119039-59-7 |
C18H22D6N2O4S |
 |
IOFETAMINE HCL |
95896-48-3 |
C12H18IN.ClH |
 |
Oxfendazole-D3(Fenbendazole sulfoxide-D3) |
1228182-54-4 |
C15H13N3O3S |
 |
Cyclopentylalbendazole |
77723-30-9 |
C14H17N3O2S |
|
|
SulfaMonoMethoxine-13C6 hydrate (see Data Sheet) |
1416768-32-5 |
|
|
|
Magnesium-24Mg solution |
|
|
|
|
MeloxicaM Related CoMpound D |
|
|
 |
DIPHENHYDRAMINE IMPURITY A |
|
C17H21NO |
|
|
IFOSFAMIDE - REFERENCE SPECTRUM |
|
|
|
|
Zilpaterol-13C3 hydrochloride |
1613439-55-6 |
|
 |
(-)-N-METHYLPHYSOSTIGMINE |
103877-07-2 |
C16H23N3O2 |
|
|
CLOSANTEL SODIUM DIHYDRATE |
|
|
|
|
EUROSOIL 4 |
|
|
 |
Zinc 67Zn solution (certified for isotope abundance ratio) |
|
Zn |
|
|
Human serum (high creatinine) |
|
|
 |
Fluticasone Propionate Resolution Mixture |
|
C28H35F3O6S |
 |
SECOBARBITAL-D5 |
130221-73-7 |
C12H13D5N2O3 |
 |
L-Cefadroxil |
144790-28-3 |
C16H17N3O5S |
 |
N,N'-desoxycarbadox |
55456-55-8 |
C11H10N4O2 |
|
|
Lithium carbonate-7Li |
|
7Li2CO3 |
 |
Oxybutynin IMpurity C |
1199574-70-3 |
C21H29NO3 |
|
|
LaMivudine Resolution Mixture C |
|
|
|
|
DIPHENOXYLATE HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
|
|
PANCREAS POWDER (PROTEASE) BRP |
|
|
|
|
OXFENDAZOLE WITH IMPURITY D |
|
|
|
|
GENOMIC DNA OF ESCHERICHIA COLI O157 (EDL 933) |
|
|
 |
CODEINE MONOHYDRATE) |
6059-47-8 |
C18H23NO4 |
|
|
GMO Standard ERM-BF411, Maize Bt-176 |
|
|
|
|
SuMatriptan Succinate Related IMpurities |
|
|
 |
Penbutolol-D9 hydrochloride |
1346605-01-3 |
C18H21ClD9NO2 |
 |
Chloroquine Related CoMpound E |
5428-61-5 |
C18H26ClN3 |
|
|
Fosinopril Related CoMpound F |
|
|
|
|
Pyrantel Related CoMpound A |
|
|
|
|
FLUMAZENIL - REFERENCE SPECTRUM |
|
|
 |
(±)-Nicotine-d3 |
1173021-00-5 |
C17H17D3N2O3 |
 |
Ciprofloxacin-D8 hydrochloride hydrate (see Data Sheet) |
1216659-54-9 |
C17H11ClD8FN3O3 |
 |
(+/-)-N-HYDROXY-3 4-METHYLENEDIOXYAMPHE& |
114562-59-3 |
C10H13NO3 |
 |
Cefoperazone dihydrate |
113826-44-1 |
C25H29N9O9S2 |
 |
Iron-56Fe solution |
|
Fe |
 |
N-ALLYLNORMETAZOCINE |
14198-28-8 |
C17H23NO |
|
|
HEPARIN LOW-MOLECULAR-MASS FOR CALIBRATION CRS |
|
|
|
|
Abacavir StereoisoMers Mixture |
|
|
|
|
Chloroquine Related CoMpound G |
|
|
|
|
AMIODARONE IMPURITY D |
|
|
 |
CHLORAMPHENICOL DISODIUM DISUCCINATE |
|
C19H20Cl2N2Na2O13-2 |
|
|
ESKETAMINE HYDROCHLORIDE - REFERENCE SPECTRUM |
|
|
 |
70476-82-3 |
70476-82-3 |
|
![3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride](/CAS/20200119/GIF/CB12541748.gif) |
3-[1-hydroxy-4-[4-(hydroxydiphenylMethyl)-1-piperidinyl]butyl]-alpha,alpha-diMethyl benzeneacetic acid hydrochloride |
|
C32H40ClNO4 |
|
|
Cefprozil Related CoMpound K |
|
|
 |
92-54-6 |
92-54-6 |
C10H14N2 |
|
|
FLECAINIDE IMPURITY A |
|
|
|
|
DANAPAROID SODIUM |
|
|
|
|
Hemoglobin HbA0 (non-glycated) |
|
|
|
|
dihydrovinpocetine |
|
|
 |
Abacavir Related CoMpound D |
1443421-69-9 |
C18H21ClN10O |
|
|
SalMeterol Related CoMpound A |
|
|
|
|
OXFENDAZOLE IMPURITY B |
|
|
|
|
(R)-TIMOLOL |
|
|
|
|
Anastrozole iMpurity E |
|
|
|
|
CitalopraM Related CoMpound G |
|
|
|
|
Orlistat Related CoMpound E |
|
|
|
|
SuMatriptan Succinate Related CoMpound C |
|
|
 |
96946-42-8 |
96946-42-8 |
|
 |
Cadmium-111Cd solution |
|
Cd |
 |
TIAPRIDE N-OXIDE |
63484-11-7 |
C15H24N2O5S |
|
|
ACECLOFENAC - REFERENCE SPECTRUM |
|
|
 |
1-(3,4-Dichlorphenyl)-5-isopropylbiguanidmonohydrochlorid |
6001-93-0 |
C11H16Cl3N5 |
|
|
Silicon (isotope ratio) |
|
|
|
|
Oxymetazoline impurity A |
|
|
|
|
Risperidone Related CoMpounds Mixture |
|
|
 |
SalMeterol Resolution Check |
|
C25H37NO4 |
 |
Octadecylhydrogenmaleat |
2424-62-6 |
C22H40O4 |
 |
IFOSFAMIDE IMPURITY E |
42453-19-0 |
C5H11Cl2N |
 |
Temazepam Related Compound F (15 mg) (7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) |
3294-96-0 |
C16H13ClN2O2 |
 |
FOSCARNET IMPURITY B |
55920-24-6 |
C3H8NaO5P |
 |
Copper-65Cu solution |
|
Cu |
 |
Boron-11B solution |
|
BH3 |
|
|
Platinum (isotope ratio) |
|
|
|
|
CeftazidiMe, Delta-3-IsoMer |
|
|
|
|
Abacavir Related CoMpounds Mixture |
|
|
 |
ZINC-64 |
|
Zn |
|
|
Vancomycin B with Monodechlorovancomycin |
|
|
|
|
Cefprozil Related CoMpound H |
|
|
|
|
TRIMETHOPRIM IMPURITY B |
|
|
 |
Temazepam Related Compound G (15 mg) (7-Chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3-dione) |
93329-92-1 |
C17H15ClN2O2 |
|
|
OXYTOCIN/DESMOPRESSIN VALIDATION MIXTURE |
|
|
|
|
POTASSIUM CLAVULANATE - REFERENCE SPECTRUM |
|
|